Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Princeton Instruments Camera Used to Measure 2D SFG Spectrum of a Peptide

Published: Friday, March 14, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
Researchers at UW-Madison measure two-dimensional sum frequency generation spectrum using PIXIS:400B CCD camera.

Princeton Instruments hails the landmark 2D SFG measurements performed on an interface-bound peptide by the Zanni group at the University of Wisconsin-Madison.

Details of this work can be found in the recently published article, “Two-Dimensional Sum-Frequency Generation Reveals Structure and Dynamics of a Surface-Bound Peptide” [J. Am. Chem. Soc., 2014, 136 (3), pp 956–962; DOI: 10.1021/ja408682s].

Led by professor of chemistry Martin Zanni, the UW-Madison research group measured the two-dimensional sum frequency generation (SFG) spectrum of a peptide bound to a gold surface using a Princeton Instruments PIXIS:400B CCD camera.

Determination of the secondary structure of interface-bound peptides is a powerful tool in the investigation of such protein-misfolding disorders as Alzheimer’s disease and diabetes.

Unlike conventional linear spectroscopic methods, 2D IR and 2D SFG provide unambiguous information about the structure and dynamics of target molecules.

Emerging nonlinear spectroscopic methods like 2D IR require highly sensitive photodetectors. Commercialized by companies such as PhaseTech Spectroscopy (Madison, WI), these increasingly popular techniques offer an exciting new approach toward resolving the challenging medical problems posed by protein-misfolding diseases.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Cancer Discovery Links Experimental Vaccine and Biological Treatment
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
Study Reveals New Method to Develop More Efficient Drugs
A new study suggests a new approach to develop highly-potent drugs which could overcome current shortcomings of low drug efficacy and multi-drug resistance in the treatment of cancer as well as viral and bacterial infections.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!